Мақаланы E-mail арқылы жіберу mRNA-based therapeutics–Advances and perspectives
- Авторлар: Sergeeva O.1,2, Koteliansky V.1,2, Zatsepin T.1,2,3
-
Мекемелер:
- Department of Chemistry
- Skolkovo Innovation Center
- The Federal Service on Customers’ Rights Protection and Human Well-being Surveillance
- Шығарылым: Том 81, № 7 (2016)
- Беттер: 709-722
- Бөлім: Review
- URL: https://journals.rcsi.science/0006-2979/article/view/150939
- DOI: https://doi.org/10.1134/S0006297916070075
- ID: 150939
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
In this review we discuss features of mRNA synthesis and modifications used to minimize immune response and prolong efficiency of the translation process in vivo. Considerable attention is given to the use of liposomes and nanoparticles containing lipids and polymers for the mRNA delivery. Finally we briefly discuss mRNAs which are currently in the clinical trials for cancer immunotherapy, vaccination against infectious diseases, and replacement therapy.
Негізгі сөздер
Авторлар туралы
O. Sergeeva
Department of Chemistry; Skolkovo Innovation Center
Хат алмасуға жауапты Автор.
Email: olga.sergeeva.v@gmail.com
Ресей, Moscow, 119991; 3 Nobel str., Moscow, 143026
V. Koteliansky
Department of Chemistry; Skolkovo Innovation Center
Email: olga.sergeeva.v@gmail.com
Ресей, Moscow, 119991; 3 Nobel str., Moscow, 143026
T. Zatsepin
Department of Chemistry; Skolkovo Innovation Center; The Federal Service on Customers’ Rights Protection and Human Well-being Surveillance
Email: olga.sergeeva.v@gmail.com
Ресей, Moscow, 119991; 3 Nobel str., Moscow, 143026; Moscow, 111123
